Latest News
Results page: [Prev] 1 2 3 ... 32 33 34 35 36 37 38 ... 40 41 42 [Next]
Prescribing by Physios and Podiatrists
Posted: Wednesday, August 28th, 2013
The Human Medicines (Amendment) Regulations 2013 SI No. 1855 largely came into force on 20th August 2013. They enact independent prescribing by appropriately trained physiotherapists and podiatrists and implement the falisfied medicines directive.
Guidance on Patient Group Directions
Posted: Wednesday, August 28th, 2013
Following the changes to NHS England structures, the PGD website and NICE guidelines have been updated.
Hospital Pharmacy Europe conference
Posted: Tuesday, August 27th, 2013
PLEA members in or associated with the hospital service may be interested in the Hospital Pharmacy Europe Conference which will be at the Hilton Birmingham Metropole on October 29th 2013. (Quote)The day will address two of the key issues facing Europe’s hospital pharmacy community: Safety and Affordability, equipping participants with the knowledge and confidence to deliver and maintain the highest standards of patient and healthcare worker safety whilst staying within budget and in accordance with European legislation
Regulations on falsified medicines now in force
Posted: Friday, August 23rd, 2013
The Human Medicines (Amendment) Regulations 2013 SI No. 1855 which implement European requirements on falsified medicines came into force on 20th August 2013. More information is available on a dedicated section of the MHRA website.
Availability of diclofenac as a P medicine
Posted: Monday, August 19th, 2013
The MHRA is consulting on the continued availability of diclofenac as a Pharmacy medicine and the safety recommendations from the Commission on Human Medicines. Consultation closes on 28th October 2013.
Tramadol to become Sch. 3 CD
Posted: Wednesday, July 24th, 2013
The Home Office has issued a consultation on the placing of tramadol in schedule 3 to the Misuse of Drugs Act 1971. The consultation also questions the continuation of the exemption from prescription requirements for temazepam. Consultation closes on 11th October 2013
Proposal to end sell through of u/l herbals
Posted: Sunday, July 14th, 2013
The MHRA is undertaking a public consultation to end the "sell through" of unlicensed herbal medicines on the market at April 2011. It propses 31st December as the cut off date. Consultation closes on 6th September 2013.
EU Court overrules EMA licensing decision
Posted: Friday, July 12th, 2013
According to an article in PharmaTimes, the European Court has over-ruled a decision by the European Court/European Medicines Agency (EMA) not to license an "orphan" drug - Orphacol (cholic acid) - for rare liver diseases. One of the lawyers involved said "This judgement is the first to provide guidance on what type of use qualifies under the "well established use" procedure for obtaining an MA, and the first to interpret the "exceptional circumstances" provision.
Assisted Dying Bill laid in House of Lords
Posted: Sunday, June 2nd, 2013
Lord Falconer's Assisted Dying Bill has now been laid in the House Of Lords. You can sign up for a regular email detailing its progress if you wish.
Informal consultation medicines and cross borders
Posted: Sunday, June 2nd, 2013
The MHRA has published an informal consultation on amendments to the medicines regulations to reflect changes to patients' rights to cross-border healthcare. These include the adoption of a "non-exhaustive list of elements to be included in a prescription to allow them to be recognised in another Member State" "Nevertheless the pharmacist will retain discretion over whether the prescription is dispensed or not" The consultation closes on 17th June 2013.
Results page: [Prev] 1 2 3 ... 32 33 34 35 36 37 38 ... 40 41 42 [Next]
These news items are not exhaustive but are selected according to their relevance to pharmacy practice, NHS community pharmacy contracts and the regulation of the pharmacy profession. If you wish to add any items that you think we have missed, contact our news editor.
